BMS-986419

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Healthy Volunteers

Phase 1

A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

CompletedNCT05932277

Bristol-Myers SquibbHealthy Volunteers

Start: 2023-06-29End: 2023-09-13Updated: 2023-10-30

A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants

CompletedNCT06846866

Bristol-Myers SquibbHealthy Volunteers

Start: 2025-02-27End: 2025-10-21Updated: 2025-11-17